Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors

Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors

US Patent 11524963 · Granted Dec 13, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases2025
Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases2025
Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases2025
Compounds for the treatment of BRAF-associated diseases and disorders2025
Compounds for the treatment of BRAF-associated diseases and disorders2025
Method for increasing number of proteins identified by mass spectrometry2025
5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases2025
FGFR3 inhibitor compounds2025
Protein tyrosine phosphatase inhibitors2025
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kin2024
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kin2024
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kin2024